By Emily Field ( August 16, 2016, 8:26 PM EDT) -- A former Pfizer medical director on Monday asked the Second Circuit to rethink its decision to uphold the dismissal of his suit claiming the company helped defraud the federal government after marketing cholesterol drug Lipitor off-label, saying the panel skipped over some key facts and legal issues....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.